← Back to headlines
BMO Capital Cuts Price Target on BioNTech SE (BNTX)
BMO Capital has reduced its price target for BioNTech SE (BNTX) from $143 to $128.
31 Mar, 15:06 — 31 Mar, 15:06
Sources
Showing 1 of 1 sources
Related Stories
Signs of depression in teenagers that parents often overlook
5h ago
74-year-old woman dies after being pulled unconscious from sea in Katerini, Greece
5h ago
August Depression: Psychologists Advise on Coping with End-of-Summer Sadness
5h ago
Heat Warnings Overlook Common Health Problems Exacerbated by Extreme Temperatures
6h ago